AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03675919 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Access to the online portal
Description: self-monitoring of health parameters
Study NCT03675919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Access to the online portal
Description: self-monitoring of health parameters
Study NCT03675919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedical coaching
Description: regular telephone calls providing information about T2DM, healthy lifestyle, low-carbohydrate diet and physical activity
Study NCT01599819 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
Description: 1 PK infusion of ADVATE (low dose in Cohort 1, high dose in Cohort 2)
Study NCT01599819 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PEGylated Recombinant Factor VIII
Description: 1 PK infusion of BAX 855 (low dose in Cohort 1, high dose in Cohort 2)
Study NCT02310360 — intervention group
Intervention type: RADIATION
Intervention: Fallypride
Study NCT03122652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 MG Oral Tablet [Aubagio]
Description: 1 tablet once a day
Study NCT03122652 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: 1 tablet once a day
Study NCT00002981 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positron emission tomography
Study NCT00002981 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: fludeoxyglucose F 18
Study NCT00002981 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: methionine C 11
Study NCT04127240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DASH diet containing daily intakes of red meat
Description: Each participant was randomized to consume 3 or 6 ounces of red meat as a part of the DASH dietary pattern for 12-weeks.
Study NCT01044056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
Description: LNG/EE oral contraceptive tablets (Microgynon® 30), 21 in total, containing 0.150 mg LNG and 0.030 mg EE per tablet administered once daily orally for 21 consecutive days.
Study NCT01044056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: norelgestrominum and ethinylestradiol patch oral contraceptive patch
Description: A contraceptive patch (EVRA ™), one patch for 7 days for three consecutive weeks, 3 patches in total, applied on the lower abdomen. Dose: per patch 6 mg norelgestromin and 0.750 mg EE releasing 0.150 mg norelgestromin and 0.020 mg EE per day.
Study NCT01044056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nuvaring ™ (etonorgestrel/ethinylestradiol)
Description: NuvaRing ™ , one ring for a period of 21 days, inserted vaginally. Dose: per ring 11.7 mg etonogestrel and 2.7 mg EE releasing a daily average amount of 0.120 mg etonogestrel and 0.015 mg EE.
Study NCT02984891 — intervention group
Intervention type: PROCEDURE
Intervention: Optical Coherence Tomography (OCT)
Description: Procedure will be performed using the OCT Dragonfly catheter is a hydrophilic-coated catheter that uses infrared light with a central wavelength between 1,250 and 1,350 nm. Axial resolution with OCT is 10-20 microns, and maximum tissue penetration with OCT is approximately 1.5 mm-3 mm.
Study NCT02984891 — intervention group
Intervention type: PROCEDURE
Intervention: Intravascular Ultrasound (IVUS)
Description: Procedure will be performed using the IVUS Kodama catheter is a hydrophilic-coated catheter that used high-fidelity ultrasound transmission to capture high-definition images of coronary artery anatomy. It uses ultrasound waves with a frequency of 40 or 60 MHz, as opposed to 20 MHz in conventional IVUS, to improve resolution while optimizing tissue penetration. It provides axial resolution of \< 40 microns and tissue penetration of 10 mm.
Study NCT04431141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin
Description: Teneligliptin alone
Study NCT04431141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: Empagliflozin alone
Study NCT04431141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin and Empagliflozin
Description: Teneligliptin and empagliflozin
Study NCT01799161 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: gp96-Ig Vaccine
Study NCT01799161 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Theophylline
Description: 300 mg capsule daily of Theophylline during 1st course, then adjusted dose
Study NCT01799161 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: 24-hr oxygen delivered via nasal cannula or oxygen mask during 1st course, then adjusted dose.
Study NCT01799161 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immunologic Evaluation
Description: Frequency of IFN-y,CD8 cells in response to vaccine in available tumor samples Blood draw to assess immunological response \[frequency of CD4+, FoxP3 (Treg), et al\] in treated patients.
Study NCT01581905 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Laparoscopic Hysterectomy (LH)
Description: Patients assigned to this intervention will undergo conventional laparoscopic hysterectomy, either total or supracervical.
Study NCT01581905 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robot Assisted Hysterectomy
Description: Patients assigned to this group will undergo Robot-Assisted Laparoscopic Hysterectomy, either total or supracervical.
Study NCT02330445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRTX-100
Description: 6 micrograms PRTX-100 per kilogram of body weight administered via infusion
Study NCT02120560 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Atrial Fibrillation Ablation
Description: Both treatment arms will undergo atrial fibrillation ablation.
Study NCT03178903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: Participants in transcranial direct current stimulation (tDCS) will receive tDCS over the dorsal-lateral prefrontal cortex for 20 minutes, 3 times per week for 8 weeks.
Study NCT03178903 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Participants in sham transcranial direct current stimulation (tDCS) will receive shame tDCS over the dorsal-lateral prefrontal cortex for 20 minutes, 3 times per week for 8 weeks.
Study NCT03178903 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Aerobic Exercise (AE)
Description: Participants will engage in supervised, 30-minute bouts of moderate-intensity exercise 3x/week for 8 weeks.
Study NCT03178903 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic Exercise (AE)
Description: Participants will engage in supervised, 30-minute bouts of moderate-intensity exercise 3x/week for 8 weeks.
Study NCT03595189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cilastatin
Description: Dose escalation 3-hour single intravenous administration
Study NCT01965587 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: novasure mirena IUS combined
Description: novasure mirena IUS combined
Study NCT05366946 — intervention group
Intervention type: OTHER
Intervention: Prevalence study
Description: Prevalence study of chronic pain in COPD vs healthy controls
Study NCT02348723 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin
Description: Patients receiving Warfarin to keep International Normalized Ratio (INR)between 2.0 - 3.0
Study NCT02348723 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran Etexilate 150mg
Description: Patients receiving Dabigatran Etexilate 150mg twice daily dosing (BID)
Study NCT03595189 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3-hour single intravenous administration
Study NCT01041391 — intervention group
Intervention type: PROCEDURE
Intervention: Discectomy-lumbar spine
Description: Lumbar intervertebral discectomy performed on patients with herniated disc that chose to have surgical intervention
Study NCT01947647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Behavior Therapy
Description: A new transdiagnostic CBT protocol for the depressive/anxiety disorders was developed and revised through two demonstration studies and one focus group. The resulting protocol involves several primary components, including psychoeducation on the symptoms of depression and anxiety (session 1), assessment of motivation and setup of treatment plans (session 2), exposure therapy (sessions 3-15), and relapse prevention (final session). In addition to these primary components, optional modules are included to supplement exposure therapy later in treatment to address secondary symptoms (e.g., anger, sleep, hypervigilance, drinking to cope). The goal of these modules is to allow providers to tailor treatment to specific symptoms that may be present in any single or set of diagnoses that may be reducing the effects from the primary exposure approach. Session will be weekly for 45-60 minutes with homework assignments to be completed between sessions.
Study NCT01947647 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Activation Therapy
Description: To provide an evidence-based comparison for the transdiagnostic CBT condition, a second group of participants will receive manualized BAT. In general, BAT involves teaching patients to monitor their mood and daily activities with the goal of increasing pleasant, reinforcing activities and reducing unpleasant events. In the present study, the BAT condition will be manualized, following an existing protocol in the literature. BAT will be structurally equivalent to the transdiagnostic CBT with the same session length (45-60 minutes), frequency of sessions (weekly), duration of treatment (12-16 sessions), and amount of homework.
Study NCT01102140 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: POMx, pomegranate polyphenol extract
Description: 1000 mg orally once daily.
Study NCT01102140 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sugar Pill
Description: Matching sugar pill
Study NCT01594086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: green tea powder
Description: Consuming 2 g/day of green tea powder in three times divided for 3 months
Study NCT04024449 — intervention group
Intervention type: OTHER
Intervention: Group A
Description: ovarian function test in control group
Study NCT03933072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: obtaining of autologous human olfactory bulb, autologous sural nerve preparation
Description: The operative procedure will be aimed to obtain one of the patient's olfactory bulbs. The operation will be performed using a minimally invasive intracranial microsurgical endoscopy-assisted or transnasal endoscopic approach. During the same operation the patient sural nerve will be prepared for a future grafting.
Study NCT03933072 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: production of Glial Neuropatch
Description: The human autologous olfactory ensheathing glia and olfactory fibroblast isolated from the olfactory bulb will be used for production of Glial Neuropatch in a laboratory facility in accordance with good manufacture procedures (GMP). The final Product will consist of the aforementioned cell suspension embedded with collagen scaffold. The European Medicines Agency/Committee for Advanced Therapies (EMA/CAT) considers that the Product Glial Neuropatch falls within the definition of a tissue engineered product of an advanced therapy medicinal product (decision EMA/CAT/293903/2018 from 22 June 2018: Scientific recommendation on classification of advanced therapy medicinal products Article 17 - Regulation (EC) No 1394/2007).
Study NCT03933072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microsurgical reconstruction of the transected spinal cord with autologous Glial Neuropatch-nerve bridges
Description: The surgery will consists of laminectomy/laminotomy, midline durotomy above the area of spinal cord lesion, detethering of the spinal cord from fibrotic adhesions, resection of the posttraumatic spinal cord glial scar, delivering of cultured OEC/ONFs explants (Glial Neuropatch) to the area of spinal cord injury and finally bridging of the spinal cord gap by harvested autologous sural nerve grafts.
Study NCT01188811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lipoic acid
Description: 1200 mg taken by mouth daily starting on day one of the study and ending on the last day of study participation.
Study NCT01188811 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo comparator will be taken by mouth daily starting on day one of the study and ending on the last day of study participation
Study NCT03893851 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactions Competencies with Children - for Teachers (ICC-T)
Description: Core training components include teacher-student interaction, maltreatment prevention, effective discipline strategies, identifying and supporting burdened students and implementation of the training materials into the school setting.
Study NCT04011306 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumina24 BLU
Description: Lumina24 BLU is the technology used to deliver continuous low-irradiance phototherapy for the treatment of acute burns
Study NCT03536273 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates Group Exercises
Description: For 12 weeks, 3 repetitions per week
Study NCT03810560 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laser device Er,Cr:YSGG laser
Description: laser device with open flap debridement
Study NCT01003288 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adjuvanted influenza H1N1split virion vaccine
Description: Vaccination Pandemrix suspension and emulsion for emulsion for injection. 1 dose (0.5 ml) contains Split influenza virus, inactivated, containing antigen 3.75 micrograms of A/California/7/2009 (H1N1)v-like strain (X-179A)~\* Pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
Study NCT00450281 — intervention group
Intervention type: GENETIC
Intervention: chromogenic in situ hybridization
Study NCT00450281 — intervention group
Intervention type: GENETIC
Intervention: gene expression analysis
Study NCT00450281 — intervention group
Intervention type: GENETIC
Intervention: mutation analysis
Study NCT00450281 — intervention group
Intervention type: GENETIC
Intervention: polymerase chain reaction
Study NCT00450281 — intervention group
Intervention type: GENETIC
Intervention: polymorphism analysis
Study NCT00450281 — intervention group
Intervention type: OTHER
Intervention: fluorescent antibody technique
Study NCT00450281 — intervention group
Intervention type: OTHER
Intervention: immunohistochemistry staining method
Study NCT00450281 — intervention group
Intervention type: OTHER
Intervention: laboratory biomarker analysis
Study NCT00450281 — intervention group
Intervention type: OTHER
Intervention: matrix-assisted laser desorption/ionization time of flight mass spectrometry
Study NCT00450281 — intervention group
Intervention type: OTHER
Intervention: study of socioeconomic and demographic variables
Study NCT00450281 — intervention group
Intervention type: PROCEDURE
Intervention: study of high risk factors
Study NCT00607009 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALIVE
Description: ALIVE email-based behavioral program based on the participants selected intervention - physical activity, fats/sugars or fruits/vegetabls
Study NCT00585247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imiquimod
Description: Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
Study NCT00585247 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
Study NCT01130012 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Lifestyle: diet and exercise
Description: Lifestyle: The women received counseling by a clinical nutritionist six times and by a physiotherapist six times during pregnancy.
Study NCT01130012 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Close follow-up: reporting diaries of food and exercise
Description: Follow-up: The women received information of the results of a glucose tolerance test (OGTT), reported food records three times during pregnancy, exercise history and exercise diaries monthly.
Study NCT02599038 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Serine supplementation
Description: Serine supplementation (200 mg/kg/day)
Study NCT02934659 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atlas(TM) Knee System
Description: The Atlas System is an extra-capsular knee implant designed to unload the medial knee.
Study NCT04933994 — intervention group
Intervention type: DEVICE
Intervention: computed Tomography
Description: All cases were detected with computed Tomography
Study NCT01730469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT1001 150 mg
Description: AT1001 150mg is available as a capsule
Study NCT00382252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: computed tomography
Study NCT00382252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positron emission tomography
Study NCT00382252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radiofrequency ablation
Study NCT02837783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linaclotide
Description: Oral, once daily
Study NCT02837783 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral, one daily
Study NCT00920712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Weiqi decotion
Description: Decoction ,two times a day
Study NCT00920712 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Weiqi decotion
Description: Decoction ,two times a day
Study NCT00663169 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: canakinumab
Description: 10 mg/kg intravenous infusion 250 mL over 2 hours.
Study NCT00663169 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone
Description: 12 mg intravenous infusion 50 mL over 30 minutes.
Study NCT00663169 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: placebo matching canakinumab
Description: 5% glucose in water intravenous infusion.
Study NCT00663169 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo matching dexamethasone
Description: Placebo intravenous infusion.
Study NCT00541710 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: genistein
Description: pills of 27 mg, twice per day for 12 months
Study NCT00541710 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: placebo
Description: sugar pills twice per day for 12 months
Study NCT00867724 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aer-O-Scope Colonoscopy
Description: Screening Colonoscopy
Study NCT03645798 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Three good things therapy
Description: To maintain an emphasis on the positive experience, participants were directed to record three good things that went well each day. These things could be minor, ordinary, or important. Next to each good thing, participants were required to answer the question: Why did this good thing happen?
Study NCT03645798 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Normal psychological instruction
Description: Normal psychological instruction is a convenient method set by the hospital. Nurses who have stress or psychological problem could find help through this intervention. It was delivered by psychologists.
Study NCT03153969 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SHOFU Beautifil II LS
Description: Placed under manufacturer's instructions
Study NCT03153969 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3M/ESPE Filtek Supreme
Description: Placed under manufacturer's instructions
Study NCT00353262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avastin
Description: 7.5mg/kg iv (cycle 3 only)
Study NCT00353262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130mg/m2 iv (cycles 1, 2 and 3)
Study NCT00353262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine [Xeloda]
Description: 1000mg/m2 po bid (cycles 1, 2 and 3)
Study NCT01239004 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 6 tablets daily, with up to 2000 mg niacin and 325 mg aspirin daily, for 12 weeks
Study NCT01239004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colesevelam
Description: 6 tablets (3750 mg total) daily, with up to 2000 mg niacin and 325 mg aspirin daily, for 12 weeks
Study NCT02067871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laser Therapy
Description: Low-level laser therapy was administered twice a week with a minimum of 48h between sessions over a period of eight weeks.
Study NCT02067871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation
Description: Neuromuscular electrical stimulation was administered twice a week with a minimum of 48h between sessions over a period of eight weeks and with progressive intensity and volume.
Study NCT00787059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ad5.hAC6
Description: Intracoronary delivery of test substance in 3:1 randomization (Ad5.hAC6 : placebo) with dose escalation, starting at 3.2 x 10\^9 vp to 10\^12 vp in 5 dose groups